Instil Bio, Inc. (TIL)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 10:20AM EDT. Market open.
| Previous close | 10.60 |
| Open | 10.60 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 10.51 - 10.60 |
| 52-week range | 6.08 - 14.00 |
| Volume | |
| Avg. volume | 15,803 |
| Market cap | 68.356M |
| Beta (5Y monthly) | 1.25 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
What Makes Instil Bio (TIL) a New Buy Stock
Instil Bio (TIL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Zacks
Instil (TIL) Stock Rises More Than 20% in a Week: Here's Why
Instil's (TIL) recent deal with a collaborator to carry out preclinical manufacturing feasibility studies on its ITIL-306 program is a positive.
- Zacks
After Plunging -18.52% in 4 Weeks, Here's Why the Trend Might Reverse for Instil Bio, Inc. (TIL)
The heavy selling pressure might have exhausted for Instil Bio, Inc. (TIL) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
© 2024 Yahoo. All rights reserved.